Hey Alisa,

 

When I recommend an eye-gaze system it really is the most reliable mode of access and funding is approved.  I have demonstrated head-pointing on an eye-gaze system for someone who is currently able to use a head-mouse but will likely need to transition to eye-gaze.  While I would feel comfortable ordering the system with the rationale that it provides multiple modes of access to accommodate his changing needs, I don’t know how approval would work.  Might be worth asking someone in funding like Lisa Williford at Eye Response.

I do know that Medicare will no longer approve a PRC device with built-in head-pointing when a patient can use a standard USB mouse or touch-screen even if there’s significant UE weakness and we anticipate that manual access will not be an option in the near future.    

 

Amy Wright, MCD, CCC-SLP

Speech Therapy Coordinator

(704) 355-0867


From: xxxxxx@xxxxxxxxxxxxxxxxxxxx [mailto:xxxxxx@xxxxxxxxxxxxxxxxxxxx] On Behalf Of Alisa Brownlee
Sent: Wednesday, November 12, 2008 3:49 PM
To: ALSA Listserv
Subject: [Assistive Technology] eye gaze system

 

Question for the group:

 

Has anyone been sucessful ordering an eye gaze unit and getting it funded for a direct selection user?  I am wondering if therapists have been ordering devices for PALS even if they do not need the eye gaze camera and are just using the touch screen or headmouse?

 

Any feedback will be appreciated.

 

Thanks,

Alisa

Alisa Brownlee, ATP
Clinical Manager, Assistive Technology Services
ALS (Lou Gehrig's Disease) Association, Greater Philadelphia Chapter

 

Assistive Technology Consultant, ALS Association, National Office


Direct Phone Number: 215-631-1877

 


This electronic message may contain information that is confidential and/or legally privileged. It is intended only for the use of the individual(s) and entity named as recipients in the message. If you are not an intended recipient of this message, please notify the sender immediately and delete the material from any computer. Do not deliver, distribute or copy this message, and do not disclose its contents or take any action in reliance on the information it contains. Thank you.